Live Status Check

NCT06146725 Recruiting Status

Real-time enrollment status for this glioblastoma clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 4:31 PM UTC

NCT06146725 Status Summary

NCT NumberNCT06146725
Recruiting StatusRecruiting
ConditionGlioblastoma
PhaseClinical Trial
Target Enrollment564 participants
Active Locations2 sites in the US
SponsorJasper Gerritsen
Last Updated on CT.govNovember 27, 2023 (Nov 27, 2023)

About NCT06146725 Enrollment Status

As of July 13, 2026: Clinical trial NCT06146725 is currently recruiting participants. This clinical trial study for glioblastoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Jasper Gerritsen. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT06146725

Is NCT06146725 still recruiting?

Yes, NCT06146725 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT06146725 recruiting?

This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT06146725?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT06146725 status last updated?

The official ClinicalTrials.gov record for NCT06146725 was last updated Nov 27, 2023 (November 27, 2023). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial